We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Resorbable Pacing Leads Can Significantly Reduce Risk After Cardiac Surgery

By HospiMedica International staff writers
Posted on 04 Nov 2022
Print article
Image: After the postoperative monitoring period, the resorbable pacing leads slowly degrade in the body (Photo courtesy of Fraunhofer Society)
Image: After the postoperative monitoring period, the resorbable pacing leads slowly degrade in the body (Photo courtesy of Fraunhofer Society)

Postoperative cardiac arrhythmias are common after cardiac surgery. They are routinely treated with external pacemakers and temporary pacing leads that are prophylactically implanted at the time of surgery. This is inherently associated with several risks: Manually extracting modern stainless steel pacing leads can result in complications as the wires can, in some cases, resist extraction due to tissue in-growth. However, if the leads are cut and left in the body, there is the risk of infection and migration; in the case of the latter, revision surgery may be required. Now, a team of researchers is developing resorbable pacing leads that can significantly reduce risk factors after cardiac surgery.

In the project “Resorbable Molybdenum Temporary Cardiac Electrodes,” or “ReMoTe CarE” for short, researchers from the Fraunhofer Society (Munich, Germany) are investigating a completely new approach: In the future, bioresorbable leads that can be left in the body and then disappear by resorption after a defined period are expected to replace conventional leads. This approach is based on the use of the metal molybdenum (Mo), which offers several advantages, such as the ability to degrade uniformly in the body, biocompatibility, and high mechanical strength and electrical conductivity. For use in bioresorbable pacing leads, it is coated with resorbable biopolymers to electrically insulate the surrounding tissue.

The researchers are testing and optimizing the mechanical, electrical and degradation properties of the materials used. The demonstrators - strands of fine metal wires that are coated with biopolymers - will be tested in preclinical studies. The objective is to avoid the complications associated with non-resorbable pacing leads. This would not only provide great relief to patients but also significantly relieve the burden on both healthcare professionals and the healthcare system.

Related Links:
Fraunhofer Society

New
Gold Member
X-Ray QA Meter
T3 AD Pro
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Endoscopy Display
E150
New
Ultrasound System
Aplio go

Print article

Channels

Surgical Techniques

view channel
Image: The HyperVue Imaging System (Photo courtesy of SpectraWAVE)

Intravascular Imaging Guidance System Optimizes Stenting Procedures for Improved Patient Outcomes

Coronary artery disease (CAD), characterized by the buildup of plaque in the arteries supplying blood to the heart, affects approximately 20.5 million adults aged 20 and older. Among CAD patients who undergo... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more